Bottles of Roundup herbicide are displayed on a shelf at a Home Depot store on June 25, 2026 in North Hollywood, California. Justin Sullivan/Getty Images North America hide title toggle title i Justin Sullivan/Getty Images North America Agrochemical and biotechnology giant Bayer has agreed to pay billions of dollars to people who sued the company alleging that the herbicide Roundup caused their cancer. On Friday, a Missouri judge gave final approval to the nationwide settlement that could cost the company up to $7.25 billion over the next few years. The money will go to thousands of people who have been or will be diagnosed with non-Hodgkin’s lymphoma, a blood cancer they say is linked to glyphosate, which is the main ingredient in Roundup. Under the agreement in Circuit Court, affected people could receive between $10,000 and $165,000 in compensation, depending on whether their work in agriculture or other occupations exposed them to higher levels of glyphosate, the age at which they were diagnosed with non-Hodgkin lymphoma and other factors. In a statement, Bayer CEO Bill Anderson called the deal a “defining milestone” that will “mitigate the risks” of pending and future litigation. Presiding Judge Timothy Boyer said it was “one of the largest settlements in the history of personal injury and mass tort class actions.” Earlier this year, the U.S. Supreme Court ruled in favor of Bayer, the German company that now owns Monsanto, finding that it could be protected from lawsuits filed in state courts over allegations that it failed to warn consumers about the carcinogenic effects of glyphosate. Roundup is the most widely used herbicide in the world. The attorney representing the plaintiffs, Christopher Seeger, said in a statement that “today’s final approval order provides guaranteed compensation to Roundup cancer victims who have waited more than a decade for justice.” The latest settlement follows an earlier one in which Bayer agreed to pay between $10 billion and $11 billion to resolve more than 100,000 claims related to Roundup. More than a decade ago, the World Health Organization’s cancer agency concluded that glyphosate is likely carcinogenic to humans. Leading scientists in the field of environmental health have echoed those concerns as recently as this year. But Bayer has steadfastly denied that its product causes cancer. The Environmental Protection Agency also concluded that it “did not identify any risks of concern from the use of glyphosate, including cancer,” although the agency is currently conducting a review of the evidence related to human health after facing intense pressure from advocates and some scientists. Concerns about the safety of glyphosate have been a lively topic for supporters of Health Secretary Robert F. Kennedy Jr. and his Make America Healthy Again agenda. However, the Trump administration has taken steps to support the herbicide maker, siding with Bayer in the Supreme Court case and issuing an executive order to promote domestic production of glyphosate. Several years ago, the company removed glyphosate from its U.S. products used in residential settings, although it is still used in the agricultural industry.